Abdominal adiposity as a risk factor for chronic diseases;Adiposidad abdominal como factor de riesgo para enfermedades crónicas

Salud Publica de Mexico

Volumn 49, Issue SPECIAL EDITION 1, 2007, Pages

  Aguilar Salinas, Carlos A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250858972     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Peeters A, Barendregt J, Willekens F, Mackenbach JP, Mamun A, Bonneaux L for NEDCOM. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Inter Med 2003;138:24-32.
2. Lemieux S, Tremblay A, Prud-Homme D, Bouchard C, Nadeau A, Despres JP. Seven year changes in body fat and visceral adipose tissue in women: associations with indexes of plasma glucose-insulin homeostasis. Diabetes Care 1996;19:983-991.
3. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998;22:1164-1171.
4. Ohlson LO, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Bjontorp P, Tibblin G. The influence of body fat distribution on the incidence of diabetes mellitus. Diabetes 1985;34:1055-1058.
5. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L on behalf of INTERHEART Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study. Lancet 2004;364:937-952.
6. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005,366(9497):1640-1649.
7. Aguilar-Salinas CA, Rojas R, Rios-Torres JM, Gómez-Pérez FJ, Olaiz G, Rull JA. The metabolic syndrome: a concept in evolution. Archi Med Res 2005:36:223-231
8. International Diabetes Federation: The International Diabetes Federation consensus worldwide definition of the metabolic syndrome. Disponible en: www.idf.org/webdata/docs/Meta_syndrome_definition.pdf. Consultado el 20 de abril de 2005.
9. Hanson R, Imperatore G, Bennett P, Knowler W. Components of the metabolic syndrome and incidence of type 2 diabetes. Diabetes 2002;51:3120-3127.
10. Aguilar-Salinas CA, Mehta R, Rojas R, Gómez-Pérez FJ, Olaiz G, Rull JA. Management of the metabolic syndrome as a strategy for preventing the macrovascular complications of type 2 diabetes: controversial issues. Curr Diab Rev 2005;1:145-158.
11. Wajchenberg BJ. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev, 2000;21:697-738.
12. Kovacs P, Stumvoll M. Fatty acids and insulin resistance in muscle and liver. Best Pract Res Clin Endocrinol Metab 2005;19:625-635.
13. Lebovitz H, Banerji MA. Point: Visceral adiposity is causally related to insulin resistance. Diabetes Care, 2005;28:2322-2325.
14. Krauss RM. Dietary and genetic probes of atherogenic dyslipidemia. Arterios Thromb Vasc Biology 2005;25:2265-2272.
15. Bays H, Mandarino L, DeFronzo R. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 2004;89:463-478.
16. Miles J, Jensen M. Counterpoint: Visceral adiposity is not causally related to insulin resistance. Diabetes Care 2005;28: 2326-2327.
17. Roden M. Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. Int J Obes (Lond) 2005;29 (Suppl 2):S111-115.
18. Unger R, Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 2001;15:312-321.
19. Goldstein B, Sacalia R. Adiponectin: a novel adipokine linking adipocyte and vascular function. JCEM 2004;89:2563-2568.
20. Yang Q, Graham T, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005:436:356-362.
21. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opinion Lipidol 2003;14:561-566.
22. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med, 2004;350:2549-2557.